Jan Pilebjer
Board member
Medical Science
MIVAC Development AB
Sweden
Biography
Jan Pilebjer, born in 1954, has an economics degree from Uppsala University and is a business developer at GU Ventures. Pilebjer is a board alternate of Toleranzia since 2014. Pilebjer has extensive experience in international senior roles within both pharmaceutical and biotechnology companies such as Nycomed, Medirox, Biopool, Baxter, Kabi Vitrum and Upjohn
Research Interest
His research interests lie in Healthcare and Medical Sciences. He is the Editor-in-Chief Member of many peer reviewed journals and his area of expertise credits him with many publications in national and international journals. He is committed to highest standards of excellence and it proves through his authorship of many books.
